NDC properties for "SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension" (RxCUI 313134)
About this data
The tables show NDC propoerties for SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension with the RxCUI 313134
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension (RxCUI 313134)
| ANDA | ANDA074650 |
|---|---|
| ANDA | ANDA077612 |
| ANDA | ANDA077785 |
| ANDA | ANDA091348 |
| ANDA | ANDA212699 |
| ANDA | ANDA214330 |
| MMSL_CODE | BD3234 |
| MMSL_CODE | CD3234 |
| NDA | NDA018615 |
| RxCUI | 313134 |
| SNOMEDCT | 766575005 |
| SPL_SET_ID | 06e3d76b-8f16-4d53-bb9f-201cb6a72fb8 |
| SPL_SET_ID | 07b8b958-4855-47d8-9cc6-681a0131ce77 |
| SPL_SET_ID | 0b25c067-6c47-211c-e063-6294a90a7ca0 |
| SPL_SET_ID | 115eb7fc-4ad0-b7f5-e063-6294a90a21c5 |
| SPL_SET_ID | 2e44d04e-e75c-4f4f-9d25-2d2fbfe8521c |
| SPL_SET_ID | 305e3f82-8979-43b2-9b63-12c5ae724c6f |
| SPL_SET_ID | 3e568a2e-421d-4456-a8bf-d983ecee7ad6 |
| SPL_SET_ID | 4eb60cd1-612c-20ab-e054-00144ff88e88 |
| SPL_SET_ID | 4eb8dbf3-616c-0bbf-e054-00144ff88e88 |
| SPL_SET_ID | 4eb92391-3964-4213-9099-4404e0c65c49 |
| SPL_SET_ID | 5ff03694-787a-409d-a95e-8422aa27499c |
| SPL_SET_ID | 6111a3c9-1406-4337-8b55-0f33120af819 |
| SPL_SET_ID | 69af86b4-9c9f-4a70-b448-97b36698f3cd |
| SPL_SET_ID | 777da85a-a776-4681-976d-326ec421cfc9 |
| SPL_SET_ID | a6182855-6287-45e9-b6b4-7b57efc9c76e |
| SPL_SET_ID | acc3df02-1e99-46e6-8a31-9b26261c6daa |
| SPL_SET_ID | b5b7aba5-f93d-46bc-a3c2-712de1c5cff3 |
| SPL_SET_ID | c6171b62-835c-465e-905e-97f70438186e |
| SPL_SET_ID | c8833d0d-9e8e-40cf-b6df-d559ea83b7b2 |
| SPL_SET_ID | c9676c8a-4597-4dcf-8944-18ecc96004e2 |
| SPL_SET_ID | e2a018ad-31aa-47d2-b96b-e7a1deee0976 |
| SPL_SET_ID | f4241086-b03c-765f-e053-2a95a90aa3f5 |
| SPL_SET_ID | fea44910-400c-4688-bedc-bbb1615cd8f5 |
| VUID | 4001955 |
| Prescribable Synonym | sulfamethoxazole 200 MG / trimethoprim 40 MG in 5 mL Oral Suspension |
| RXNAV_STR | sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension |
| RxNorm Name | sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension |
| RxNorm Synonym | SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension |
| RxNorm Synonym | sulfamethoxazole 100 MG / trimethoprim 20 MG per 2.5 ML Oral Suspension |
| RxNorm Synonym | sulfamethoxazole 200 MG / trimethoprim 40 MG per 5 ML Oral Suspension |
| RxNorm Synonym | sulfamethoxazole 800 MG / trimethoprim 160 MG per 20 ML Oral Suspension |
| Related queries | Interactions (for RxCUI 313134) |
NDC Properties
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |
NDC Item 00121085320
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-20 |
| NDC Item | 00121085320 |
| Packaging | 10 CUP, UNIT-DOSE in 1 TRAY (0121-0853-20) / 20 mL in 1 CUP, UNIT-DOSE |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-08-05 |
| Marketing status | active |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121085340
| NDC 9 | 0121-0853 |
|---|---|
| NDC 10 | 0121-0853-40 |
| NDC Item | 00121085340 |
| Packaging | 4 TRAY in 1 CASE (0121-0853-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-0853-20) |
| COLORTEXT | red |
| Color | C48326 __ |
| FDA SPL set id | 620202 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2024-05-06 |
| Marketing effective time low | 1983-07-01 |
| Marketing status | COMPLETED |
| NDA | NDA018615 |
| Related queries | Properties for NDC 9 0121-0853 |
NDC Item 00121479320
| NDC 9 | 0121-4793 |
|---|---|
| NDC 10 | 0121-4793-20 |
| NDC Item | 00121479320 |
| Packaging | 4 TRAY in 1 CASE (0121-4793-20) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 13974 |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2008-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0121-4793 |
NDC Item 00527518070
| NDC 9 | 0527-5180 |
|---|---|
| NDC 10 | 0527-5180-70 |
| NDC Item | 00527518070 |
| Packaging | 473 mL in 1 BOTTLE (0527-5180-70) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 716949 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2007-01-24 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0527-5180 |
NDC Item 17856049601
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-1 |
| NDC Item | 17856049601 |
| Packaging | 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049602
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-2 |
| NDC Item | 17856049602 |
| Packaging | 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049603
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-3 |
| NDC Item | 17856049603 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | Atlantic Biologicals Corps |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049604
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-4 |
| NDC Item | 17856049604 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-4) / 5 mL in 1 CUP, UNIT-DOSE (17856-0496-1) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049605
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-5 |
| NDC Item | 17856049605 |
| Packaging | 50 CUP, UNIT-DOSE in 1 BOX (17856-0496-5) / 20 mL in 1 CUP, UNIT-DOSE (17856-0496-3) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 17856049606
| NDC 9 | 17856-0496 |
|---|---|
| NDC 10 | 17856-0496-6 |
| NDC Item | 17856049606 |
| Packaging | 72 CUP, UNIT-DOSE in 1 BOX (17856-0496-6) / 10 mL in 1 CUP, UNIT-DOSE (17856-0496-2) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 781087 |
| Labeler | ATLANTIC BIOLOGICALS CORP. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17856-0496 |
NDC Item 50090052500
| NDC 9 | 50090-0525 |
|---|---|
| NDC 10 | 50090-0525-0 |
| NDC Item | 50090052500 |
| Packaging | 473 mL in 1 BOTTLE (50090-0525-0) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 738837 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-0525 |
NDC Item 50090458400
| NDC 9 | 50090-4584 |
|---|---|
| NDC 10 | 50090-4584-0 |
| NDC Item | 50090458400 |
| Packaging | 473 mL in 1 BOTTLE (50090-4584-0) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 537970 |
| Labeler | A-S Medication Solutions LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-4584 |
NDC Item 50090578600
| NDC 9 | 50090-5786 |
|---|---|
| NDC 10 | 50090-5786-0 |
| NDC Item | 50090578600 |
| Packaging | 473 mL in 1 BOTTLE (50090-5786-0) |
| ANDA | ANDA077785 |
| COLORTEXT | pink(pinkish-orange) |
| Color | C48328 __ |
| FDA SPL set id | 692755 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-5786 |
NDC Item 50383082316
| NDC 9 | 50383-823 |
|---|---|
| NDC 10 | 50383-823-16 |
| NDC Item | 50383082316 |
| Packaging | 473 mL in 1 BOTTLE (50383-823-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-823 |
NDC Item 50383082416
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-16 |
| NDC Item | 50383082416 |
| Packaging | 473 mL in 1 BOTTLE (50383-824-16) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082420
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-20 |
| NDC Item | 50383082420 |
| Packaging | 20 mL in 1 CUP, UNIT-DOSE |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 50383082421
| NDC 9 | 50383-824 |
|---|---|
| NDC 10 | 50383-824-21 |
| NDC Item | 50383082421 |
| Packaging | 4 TRAY in 1 CASE (50383-824-21) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-824-20) |
| ANDA | ANDA074650 |
| COLORTEXT | PURPLE(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 662333 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50383-824 |
NDC Item 52959076603
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-03 |
| NDC Item | 52959076603 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076604
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-04 |
| NDC Item | 52959076604 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076605
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-05 |
| NDC Item | 52959076605 |
| Packaging | 100 mL in 1 BOTTLE (52959-766-05) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076607
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-07 |
| NDC Item | 52959076607 |
| Packaging | 118 mL in 1 BOTTLE (52959-766-07) |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 52959076608
| NDC 9 | 52959-766 |
|---|---|
| NDC 10 | 52959-766-08 |
| NDC Item | 52959076608 |
| ANDA | ANDA074650 |
| FDA SPL set id | 57206 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 52959-766 |
NDC Item 62135074947
| NDC 9 | 62135-749 |
|---|---|
| NDC 10 | 62135-749-47 |
| NDC Item | 62135074947 |
| Packaging | 473 mL in 1 BOTTLE (62135-749-47) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-749 |
NDC Item 62135087324
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-24 |
| NDC Item | 62135087324 |
| Packaging | 2 TRAY in 1 BOX (62135-873-24) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-873-52) |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62135087352
| NDC 9 | 62135-873 |
|---|---|
| NDC 10 | 62135-873-52 |
| NDC Item | 62135087352 |
| Packaging | 20 mL in 1 CUP |
| ANDA | ANDA077785 |
| COLORTEXT | orange(opaque pinkish orange) |
| Color | C48331 __ |
| FDA SPL set id | 789108 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62135-873 |
NDC Item 62559055016
| NDC 9 | 62559-550 |
|---|---|
| NDC 10 | 62559-550-16 |
| NDC Item | 62559055016 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (62559-550-16) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 675759 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 62559-550 |
NDC Item 63629196901
| NDC 9 | 63629-1969 |
|---|---|
| NDC 10 | 63629-1969-1 |
| NDC Item | 63629196901 |
| Packaging | 473 mL in 1 BOTTLE (63629-1969-1) |
| ANDA | ANDA077612 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 698587 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-12-31 |
| Marketing effective time low | 2020-02-11 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-1969 |
NDC Item 65862049601
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-01 |
| NDC Item | 65862049601 |
| Packaging | 100 mL in 1 BOTTLE (65862-496-01) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049647
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-47 |
| NDC Item | 65862049647 |
| Packaging | 473 mL in 1 BOTTLE (65862-496-47) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 65862049650
| NDC 9 | 65862-496 |
|---|---|
| NDC 10 | 65862-496-50 |
| NDC Item | 65862049650 |
| Packaging | 50 mL in 1 BOTTLE (65862-496-50) |
| ANDA | ANDA091348 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 802595 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 65862-496 |
NDC Item 66993072757
| NDC 9 | 66993-727 |
|---|---|
| NDC 10 | 66993-727-57 |
| NDC Item | 66993072757 |
| Packaging | 473 mL in 1 BOTTLE, PLASTIC (66993-727-57) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 746135 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 66993-727 |
NDC Item 67296112901
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-1 |
| NDC Item | 67296112901 |
| Packaging | 100 mL in 1 BOTTLE (67296-1129-1) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296112902
| NDC 9 | 67296-1129 |
|---|---|
| NDC 10 | 67296-1129-2 |
| NDC Item | 67296112902 |
| Packaging | 200 mL in 1 BOTTLE (67296-1129-2) |
| ANDA | ANDA091348 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 797118 |
| Labeler | RedPharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-06-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1129 |
NDC Item 67296150201
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-1 |
| NDC Item | 67296150201 |
| Packaging | 100 mL in 1 BOTTLE (67296-1502-1) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296150202
| NDC 9 | 67296-1502 |
|---|---|
| NDC 10 | 67296-1502-2 |
| NDC Item | 67296150202 |
| Packaging | 200 mL in 1 BOTTLE (67296-1502-2) |
| ANDA | ANDA074650 |
| COLORTEXT | purple(light purple) |
| Color | C48327 __ |
| FDA SPL set id | 801255 |
| Labeler | Redpharm Drug, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1997-12-29 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1502 |
NDC Item 67296191601
| NDC 9 | 67296-1916 |
|---|---|
| NDC 10 | 67296-1916-1 |
| NDC Item | 67296191601 |
| Packaging | 100 mL in 1 BOTTLE (67296-1916-1) |
| ANDA | ANDA214330 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799550 |
| Labeler | Redpharm Drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-1916 |
NDC Item 67296208501
| NDC 9 | 67296-2085 |
|---|---|
| NDC 10 | 67296-2085-1 |
| NDC Item | 67296208501 |
| Packaging | 100 mL in 1 BOTTLE, PLASTIC (67296-2085-1) |
| ANDA | ANDA077612 |
| COLORTEXT | pink |
| Color | C48328 __ |
| FDA SPL set id | 799564 |
| Labeler | Redpharm drug |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67296-2085 |
NDC Item 68788860704
| NDC 9 | 68788-8607 |
|---|---|
| NDC 10 | 68788-8607-4 |
| NDC Item | 68788860704 |
| Packaging | 473 mL in 1 BOTTLE (68788-8607-4) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 778936 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-03-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68788-8607 |
NDC Item 70748013401
| NDC 9 | 70748-134 |
|---|---|
| NDC 10 | 70748-134-01 |
| NDC Item | 70748013401 |
| Packaging | 473 mL in 1 BOTTLE (70748-134-01) |
| ANDA | ANDA212699 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 636281 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2034-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70748-134 |
NDC Item 70954025810
| NDC 9 | 70954-258 |
|---|---|
| NDC 10 | 70954-258-10 |
| NDC Item | 70954025810 |
| Packaging | 473 mL in 1 BOTTLE (70954-258-10) |
| ANDA | ANDA214330 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 805311 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70954-258 |